>>> Biotech (IBB +0.5%) extends last week's breakout after MRK pays 239% premium Biotech extends last week's breakout after MRK pays 239% premium for HCV company IDIX GILD is down 4% on competetive threats as the co's blockbuster Sovali Drug treats Hep-C.
